Specialist Paediatric Palliative Care Services (SPPCSs) have been developed rapidly over the last three decades, but as a medical subspecialty are still in their infancy. Despite advances in the treatment of childhood cancer, some children continue to die from their disease, with cancer being the second most common cause of death in children and young people aged 0--19 years of age ([@bib18]). SPPCSs are therefore an important component of children\'s oncology services, and ensuring that equitable access to palliative care services is one of the aims set out in the Improving Outcomes Guidance published in 2005 ([@bib15]), and were highlighted again by the Department of Health as an important component of the Oncology and Malignant Haematology specialised paediatric services in 2008 ([@bib5]). In the United Kingdom, approximately a third of children and young people who die from cancer have been referred to SPPCS before death and this proportion has not changed since 1990 ([@bib7]). Referral to SPPCS for children with life-limiting conditions has resulted in more children dying in the community (home or hospice) than hospital ([@bib6]). SPPCS vary across the world, for example, services were available in 58% of Children\'s Oncology Group institutions, the majority of which are in North America, but were only used by a small minority of patients ([@bib9]), and in Taiwan, only 7.2% of children who subsequently died from cancer had been cared for by a hospice ([@bib24]). In two states in the United States, a survey of paediatricians found that 74% of them were reluctant to refer patients to SPPCS, with the main reasons being related to family reluctance to accept palliative care, families viewing palliative care as giving up and difficulty in determining the right time to refer to palliative care ([@bib10]).

Children with cancer who are dying are frequently admitted to hospital which can be disrupting and distressing for the child and their family. A reduction in these events would potentially have clinical, social and economic benefits, but, currently, no data are available on the pattern or numbers of hospital admissions that occur during end of life care, and no literature has been published on whether the involvement of SPPCS might reduce hospital inpatient admissions and benefit this group. Yorkshire, UK, has a unique combination of overlapping data sets on childhood cancers, hospital admissions and children accessing SPPCS that has allowed us to measure the impact of SPPCS on the number of hospital admissions in children before their death from cancer.

Materials and methods
=====================

The cohort for this study was extracted from the Yorkshire Specialist Register of Cancer in Children and Young People (YSRCCYP) and includes patients aged 0--19 years diagnosed from 1990 to 2009. Only individuals resident in the former Yorkshire Regional Health Authority (Yorkshire) were included to have comparative 'catchment\' areas to the SPPCS.

The YSRCCYP contains clinical and demographic information on all children and young people diagnosed with cancer in Yorkshire. Data used in these analyses included age at diagnosis, gender, date of death, deprivation category, year of diagnosis and International Classification of Childhood Cancer (ICCC) diagnostic groups ([@bib23]). Date of death recorded on the YSRCCYP is obtained through automated death notifications from the Office for National Statistics death registration records. Deprivation category was determined using the Townsend deprivation score, which is based on unemployment, non-car ownership, non-home ownership and household overcrowding ([@bib19]). Townsend deprivation scores were derived by English census output area of residence at time of diagnosis using 2001 census data, and were split into five categories from least deprived to most deprived. The ICCC groups were aggregated for certain analyses to avoid small numbers into: leukaemia (I), lymphoma (II), central nervous system (CNS) tumours (III) and other solid tumours (IV--XII). Ethnic group was assigned from the linked data (see below).

Linked data
-----------

The SPPCS in the former Yorkshire Regional Health Authority is provided by [@bib13]. Martin House Children\'s Hospice has been caring for children and young adults (aged up to 35 years) with life-limiting conditions since 1987. In this SPPCS, medical support was slowly increased from part to full time in house cover (between 1987 and 2004), and a full time consultant in Paediatric Palliative Medicine was appointed from 2004 onwards.

Using data collected by the SPPCS, any individual who had been accepted for care by the SPPCS was flagged on the YSRCCYP.

In addition to this, inpatient hospital episode statistics (HES) data were linked to the YSRCCYP. HES data contains all admissions to National Health Service hospitals in England ([@bib17]), and although this data has been recorded for inpatient admissions since 1989, it was not deemed to be complete enough for research purposes until 1996. Thus, all individuals registered on the YSRCCYP who were alive from 1 January 1996 onwards were linked to inpatient HES data.

Data manipulation
-----------------

The HES data provide details on individual 'finished consultant episodes\' (FCEs). An FCE is not the same as a hospital admission; one hospital admission can comprise one or more FCEs if a patient is cared for by more than one consultant during their admission ([@bib17]). Therefore, continuous inpatient spells (CIPSs) were constructed for each patient, each CIPS representing each unique admission for every patient. A detailed description of the algorithm used to create the CIPS is given in the user guide by the [@bib14].

Planned hospital admissions are the basis of treatment for most paediatric cancer patients, so in order to assess the potential impact of palliative care involvement, each hospital admission was classified as planned (elective) or emergency (all other admission codes, \>97% were emergency admissions in this cohort) using the admission method codes recorded in the first FCE in each CIPS.

A 'proxy date of referral\' for patients who had died and were not referred for SPPCS was estimated by simulating the time from diagnosis to referral from a negative binomial distribution based on those patients who were referred to SPPCS ([Figure 1](#fig1){ref-type="fig"}). The simulation was performed by ICCC group, and summaries of the referral time periods are given in [Table 1](#tbl1){ref-type="table"}. This allowed the number of hospital admissions (total, planned and emergency) for this time period to be calculated for each individual. This method was preferred to simply analysing the rate of admissions in a predefined period (for example, 3 or 6 months before death) as the disease trajectories varied widely between the ICCC groups.

Assignment of ethnic category was achieved using ethnicity as recorded within HES data. Ethnicity within HES should be self-reported by the patient. Individuals with multiple ethnicity codes were assigned their most commonly reported ethnicity group unless the most common ethnicity was 'not known\' ([@bib16]). The 16 census ethnic groups ([@bib2]) were merged into four combined groups to avoid very small numbers in some categories: White (White: British; White: Irish; White: Other White), South Asian (Asian or Asian British: Indian; Asian or Asian British: Pakistani; Asian or Asian British: Bangladeshi; Asian or Asian British: Other Asian), Black (Black or Black British: Black Caribbean; Black or Black British; Black African; Black or Black British: Other Black) and other ethnic groups (Mixed: White and Black Caribbean; Mixed: White and Black African; Mixed: White and Asian; Mixed: other mixed, chinese and other ethnic group).

Statistical analyses
--------------------

The clinical and demographic variables were described for the whole cohort and subdivided into those who had died without referral to SPPCS and those who had been referred for SPPCS. As no previous literature exists on hospital admissions occurring during end of life care for childhood cancer, the variables included within the analysis as mentioned previously were chosen based on standard variables used within the literature of survival of childhood cancer ([@bib26]; [@bib12]; [@bib1]; [@bib25]). The impact of referral on SPPCS was explored using negative binomial regression modelling (which was chosen over Poisson regression due to overdispersion), with the total number of hospital admissions as the main outcome. We modelled hospital admission rates by including each person\'s post-referral follow-up time in the model as an exposure term. Two further negative binomial regression models were run with number of planned hospital admissions and the total number of emergency hospital admissions during the same time period.

Ethics
------

The YSRCCYP is a member of the UK Association of Cancer Registries, which currently holds section 251 permission from the National Information Governance Board to hold and process data on children and young people with cancer without obtaining consent. Ethical approval for this study was obtained from the Bradford NHS Ethics Committee (09/H1302/81).

Results
=======

There were 2508 individual patients diagnosed between 1990 and 2009, aged 0--19 years and registered on the YSRCCYP ([Table 2](#tbl2){ref-type="table"}). Of these, 26.2% (*n*=657) had died before the extract date (31 August 2011). In total, 211 children had been referred to SPPCS, of which 182 had died before the extract date ([Figure 2](#fig2){ref-type="fig"}). Therefore, 27.7% of those who had died were referred to SPPCS before death.

The groups (those who died and had been referred (*n*=182) compared with those who died and were not referred to SPPCS (*n*=475)) did not differ significantly in terms of gender, deprivation category, ethnicity or year group of diagnosis. The age groups did differ significantly with a smaller percentage in the oldest age group referred to SPPCS. The groups also differed in terms of ICCC diagnostic category with CNS tumours forming the largest subgroup in those referred to SPPCS ([Table 2](#tbl2){ref-type="table"}).

The linkage rate to the HES data set was 89.1% in this cohort. Those who did not link tended to be male, were diagnosed under the age of 5 and were diagnosed towards the beginning of the study period. This linkage rate did not differ significantly between the SPPCS group and the remainder of the cohort ([Table 3](#tbl3){ref-type="table"}). The mean number of total hospital admissions between referral and death was higher in the group not referred to SPPCS (14.1 *vs* 4.7, *t*=4.11, *P*\<0.001) as were the number of planned hospital admissions between referral and death (10.0 *vs* 2.6, *t*=4.01, *P*\<0.001), and the mean number of emergency admissions during this time period (4.1 *vs* 2.1, *t*=2.97, *P*=0.003).

The results from the adjusted negative binomial model ([Table 4](#tbl4){ref-type="table"}) showed that patients referred to SPPCS had significantly lower planned admission rates compared with those who were not referred (incidence rate ratio (IRR)=0.60, 95% CI 0.43--0.85), however, there was no significant effect of referral on overall admission rates or emergency admission rates. Children diagnosed at an older age had significantly fewer hospital admission rates by 3% (IRR=0.97, 95% CI 0.95--1.00) for total admissions. This effect was also seen in planned hospital admissions, but not for emergency hospital admissions. Children with CNS tumours had significantly fewer total hospital admissions compared with those with leukaemia (IRR=0.41, 95% CI 0.28--0.61), which was consistent in both emergency and planned hospital admissions. In addition, the models show a significant increase in total emergency and planned hospital admissions for every year increase over the study period, 1990--2009 (total admissions IRR=1.09, 95% CI 1.06--1.12).

Discussion
==========

This novel study has shown that although less than a third of children and young people who died of their cancer were referred to a SPPCS, a referral was significantly associated with fewer planned hospital inpatient admissions, by 40% on average. This is a particularly significant finding in the general context of increasing hospitalisation rates for survivors of childhood and adolescent cancer and was seen consistently across all four major diagnostic groups. An explanation for the relatively small proportion of people referred to SPCCS is unclear; possible reasons might include family reluctance to accept palliative care and a lack of education about SPCCS ([@bib10]), or ease of access and proximity to Martin House. Hospital admissions are considered socially disruptive and financially draining for children and families, and more hospital admissions have been associated with distress in fathers of childhood cancer patients ([@bib21]) and a higher risk of poor adjustment in siblings ([@bib22]). Delivery of appropriate end of life care that reduces the frequency of these events would be beneficial to patients and their families, as well as the NHS. Martin House offer a range of services that could help reduce hospital admissions, including a 24-h on-call medical service, with the ability for home visits as well as the ability to manage symptoms as inpatients when needed.

The World Health Organisation definition of paediatric palliative care states that 'It begins when illness is diagnosed, and continues regardless of whether or not a child receives treatment directed at the disease.\' However, the adult palliative care model, whereby palliative care is a phase that starts after disease-directed treatment has failed, tends to be followed in paediatric oncology patients. This may explain why the groups of patients who were not referred for SPPCS had significantly higher planned hospital admission rates than the SPPCS group, that is, they may still be receiving tumour-directed treatment, which could mean they are more likely to be admitted for side effects from treatment. A previous UK publication ([@bib20]), which looked at the number of hospital episodes by place of death in children who died from cancer, showed those patients who died at home or in a hospice spent fewer days in hospital in the last 6 months of life than those who had died in hospital. Our results are consistent with these observations, but this was a descriptive analysis, and involvement of SPPCS was not known in these patients. The place of death was not available for the patients in the current study.

Children with CNS tumours had a significantly lower rate of admissions to hospital (whether planned or emergency) compared with leukaemia (by 60% on average). There are several reasons that may explain this finding. Inpatient treatment of CNS tumours is less likely than for leukaemia because the mainstay of leukaemia treatment is chemotherapy and as such there is a higher incidence of immunosupression and therefore an increased risk of febrile neutropenia. Side effects from CNS tumours, such as vomiting or swelling, around the tumour in response to steroids can be managed at home, making inpatient treatments less likely for this group. CNS tumours are a heterogeneous group of tumours, including a spectrum of both low and high grade tumours, compared with a homogenous group of leukaemia patients who are treated on inpatient-intensive treatment protocols.

The trend in children diagnosed more recently having higher rates of hospital admissions may represent changes in practice, such as increased levels of therapy and the use of aggressive relapse treatments. Although this study was not designed to assess the health economics of hospital admissions *vs* SPPCS care, the reduction in hospitalisation rates for planned admissions associated with referral to SPPCS helps to ameliorate the impact of increasing admissions rates over time, and such reductions clearly would be financially beneficial to the NHS.

The Department of Health Children and Young People\'s Health Outcomes Forum has called for improved quality and availability of data on children with disability, life-limiting conditions and complex needs in which children with cancer are included ([@bib11]). This study provides valuable evidence for the benefit of the involvement of SPPCS in the care of the child dying from cancer. This information will also be useful for the Department of Health in England\'s Palliative Care Funding Review ([@bib8]) and local commissioners ([@bib3]; [@bib4]).

Strengths of this study include its population base, size and quality utilising 20 years of routinely collected data, but it is not without its limitations. Missing ethnicity data hampered any meaningful assessment of inequalities in relation to outcomes or service access by the ethnic group, and the availability of the HES data was restricted to the period from 1996 onwards.

The study relied on successful linkage of the HES and YSRCCYP data, as well as successfully flagging up of those referred to SPCCS on the YSRCCYP. Although both these methods were carried out using detailed linking approaches, typographical errors for some of the data could have led us to miss some patients. Although the linkage rate of HES to the YSRCCYP was high (89.1%), there were some differences between those cases that linked and those that did not. Cases less likely to link tended to be diagnosed towards the beginning of the study period, be under the age of 5 and be male. As the cohort of those referred to SPCCS was small, data were carefully interrogated to ensure matches were not missed based on simple typographical errors.

In order to compare the rate of admissions between those who were and were not referred to SPCCS, we used a proxy date for referral in patients who were not referred to SPCCS. A simulation approach to estimate the date of referral was adopted in an attempt to minimise any biases, as would be caused by simply using an average value, such as the mean or median. This approach was preferred to the option of looking at admissions in a specific time period towards the end of life (i.e., 6 months), because of the variations in disease trajectories between diagnostic groups.

We investigated inpatient hospital admissions but additional sources of hospital contact include outpatient visits and accident and emergency (A&E) department attendances. This data have been collected more recently by the NHS, and future work should include an assessment of A&E usage among these patients.

Conclusions
===========

Although less than a third of children and young people who subsequently died of cancer were referred to a SPPCS before death, referral was significantly associated with lower rates of planned hospital admissions in this cohort of children. The SPPCS clearly have a role in reducing hospital admissions during end of life care of paediatric cancer patients with potential personal, social and economic benefits.

This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
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###### Time from diagnosis to referral to specialist palliative care service by ICCC classification

  --------------------------------------------- ------------------------ ------------------------------------ --------- ------
  **ICCC classification**                       **Number of Patients**   **Median time to referral (days)**   **IQR**   
  Leukaemia                                     32                       518                                  363       995
  Lymphoma                                      14                       368                                  189       595
  CNS                                           84                       262                                  110       1206
  Neuroblastoma                                 19                       319                                  157       647
  Retinoblastoma                                0                        ---                                  ---       ---
  Renal                                         6                        390                                  78        1205
  Hepatic                                       3                        122                                  49        339
  Bone                                          18                       561                                  206       678
  Soft tissue                                   29                       273                                  194       562
  Germ cell                                     2                        169                                  125       212
  Other epithelial[a](#t1-fn2){ref-type="fn"}   3                        582                                  109       824
  Other                                         0                        ---                                  ---       ---
  --------------------------------------------- ------------------------ ------------------------------------ --------- ------

Abbreviations: CNS=central nervous system; ICCC=International Classification of Childhood Cancer; IQR=inter quartile range.

Classification includes: adrenocortical carcinomas, thyroid carcinomas, nasopharyngeal carcinomas, malignant melanomas and other unspecified carcinomas.

###### Clinical and demographic information

                                           **Yorkshire specialist register of cancer in children and young people**   **Martin house childrens\' hospice**                                                            
  --------------------------------------- -------------------------------------------------------------------------- -------------------------------------- ---------- ----------- ----------- ----------- ---------- -----------
                                                                          **Total**                                                **col %**                 **Died**   **col %**   **Total**   **col %**   **Died**   **col %**
  Total                                                                      2508                                                     100                      657         100         211         100        182         100
  **Gender**                                                                                                                                                                                                          
   Male                                                                      1551                                                     61.8                     481        73.2         153        72.5        132        72.5
   Female                                                                    957                                                      38.2                     176        26.8         58         27.5         50        27.5
  **Age group at diagnosis**                                                                                                                                                                                          
   0--4 years                                                                932                                                      37.2                     253        38.5         91         43.1         73        40.1
   5--9 years                                                                510                                                      20.3                     125        19.0         57         27.0         50        27.5
   10--14 years                                                              533                                                      21.2                     147        22.4         49         23.2         45        24.7
   15--19 years                                                              533                                                      21.2                     132        20.1         14          6.6         14         7.7
  **Ethnic category**                                                                                                                                                                                                 
   White                                                                     1676                                                     66.8                     328        49.9         125        59.2        100        54.9
   Mixed                                                                      12                                                      0.5                       3          0.5          2          0.9         2          1.1
   South Asian                                                               176                                                      7.0                       42         6.4          6          2.8         6          3.3
   Black                                                                      16                                                      0.6                       3          0.5          2          0.9         1          0.5
   Other                                                                      31                                                      1.2                       11         1.7          7          3.3         6          3.3
   Not known[a](#t2-fn2){ref-type="fn"}                                      597                                                      23.8                     270        41.1         69         32.7         67        36.8
  **Deprivation category**                                                                                                                                                                                            
   1 (least deprived)                                                        480                                                      19.1                     134        20.4         34         16.1         28        15.4
   2                                                                         514                                                      20.5                     120        18.3         41         19.4         36        19.8
   3                                                                         443                                                      17.7                     106        16.1         41         19.4         36        19.8
   4                                                                         407                                                      16.2                     112        17.1         41         19.4         34        18.7
   5 (most deprived)                                                         663                                                      26.4                     185        28.2         54         25.6         48        26.4
   Not Known                                                                  1                                                       0.0                       0           0           0           0          0           0
  **ICCC diagnostic category**                                                                                                                                                                                        
   Leukaemia                                                                 703                                                      28.0                     170        25.9         33         15.6         24        13.2
   Lymphoma                                                                  369                                                      14.7                      61         9.3         14          6.6         13         7.1
   CNS                                                                       508                                                      20.3                     164        25.0         84         39.8         72        39.6
   Neuroblastoma                                                             145                                                      5.8                       66        10.0         19          9.0         18         9.9
   Retinoblastoma                                                             58                                                      2.3                       1          0.2          0           0          0           0
   Renal                                                                     119                                                      4.7                       19         2.9          6          2.8         4          2.2
   Hepatic                                                                    23                                                      0.9                       8          1.2          3          1.4         3          1.6
   Bone                                                                      128                                                      5.1                       57         8.7         18          8.5         18         9.9
   Soft tissue                                                               209                                                      8.3                       82        31.8         29         13.7         26         0.5
   Germ Cell                                                                 178                                                      7.1                       15         2.3          2          0.9         1          0.5
   Other epithelial                                                           64                                                      2.6                       12         1.8          3          1.4         3          1.6
   Other                                                                      4                                                       0.2                       2          0.3          0           0          0           0
  **Year diagnosis**                                                                                                                                                                                                  
   1990--1994                                                                618                                                      24.6                     219        33.3         63         29.9         57        31.3
   1995--1999                                                                595                                                      23.7                     186        28.3         60         28.4         53        29.1
   2000--2004                                                                667                                                      26.6                     144        21.9         54         25.6         44        24.2
   2005--2009                                                                628                                                      25.0                     108        16.4         34         16.1         28        15.4

Abbreviations: col=column; CNS=central nervous system; ICCC=International Classification of Childhood Cancer.

Ethnic category was obtained from HES so only available for those alive in 1996 and successfully linked to HES.

###### Summary of hospital admissions by referral status

                                                                                                              **YSRCCYP**     **Not referred to SPPCS**   **Referred to SPPCS**
  -------------------------------------------------------------------------------------------------------- ----------------- --------------------------- -----------------------
  Total deaths                                                                                                    657                    475                       182
  Eligible for HES linkage                                                                                        497                    350                       147
  Successful linkage to HES                                                                                   443 (89.1%)            311 (88.9%)               132 (89.8%)
                                                                                                            **Mean (s.d.)**        **Mean (s.d.)**           **Mean (s.d.)**
  Total number of hospital admissions between referral to SPPCS and death[a](#t3-fn2){ref-type="fn"}          11.3 (22.7)            14.1 (25.8)               4.7 (10.3)
  Number of planned hospital admissions between referral to SPPCS and death[a](#t3-fn2){ref-type="fn"}        7.8 (18.0)             10.0 (20.7)                2.6 (6.0)
  Number of emergency hospital admissions between referral to SPPCS and death[b](#t3-fn3){ref-type="fn"}       3.5 (6.1)              4.1 (6.3)                 2.1 (5.2)

Abbreviations: HES=hospital episode statistics; SPPCS=Specialist Paediatric Palliative Care Service; YSRCCYP=Yorkshire Specialist Register of Cancer in Children and Young People.

*P*\<0.0001 *t*-test.

*P*=0.003 *t*-test.

###### Negative binomial models with number of hospital admissions as the outcomes

                                  **Model A: total number of admissions**   **Model B: emergency admissions**   **Model C: planned admissions**                                                                
  ------------------------------ ----------------------------------------- ----------------------------------- --------------------------------- --------- ------ ------ ------ --------- ------ ------ ------ ---------
  **Age at Diagnosis (years)**                     0.97                                   0.95                               1.00                  0.019    0.98   0.96   1.01    0.170    0.97   0.94   0.99    0.020
  **ICCC**                                                                                                                                                                                                     
   Leukaemia                                        REF                                                                                                     REF                            REF                      
   Lymphoma                                        0.79                                   0.49                               1.28                  0.342    0.95   0.58   1.56    0.827    0.71   0.41   1.24    0.235
   CNS                                             0.41                                   0.28                               0.61                 \<0.001   0.56   0.37   0.84    0.005    0.33   0.21   0.52   \<0.001
   Other solid tumours                             0.84                                   0.60                               1.18                  0.323    0.85   0.60   1.22    0.391    0.85   0.57   1.27    0.424
  **Gender**                                                                                                                                                                                                   
   Male                                             REF                                                                                                     REF                            REF                      
   Female                                          0.93                                   0.73                               1.20                  0.595    0.98   0.75   1.27    0.858    0.90   0.67   1.22    0.510
  **Referred to SPPCS**                                                                                                                                                                                        
   No                                               REF                                                                                                     REF                            REF                      
   Yes                                             0.79                                   0.59                               1.05                  0.106    1.15   0.84   1.58    0.375    0.60   0.43   0.85    0.004
  **Deprivation category**                                                                                                                                                                                     
   1 (least deprived)                               REF                                                                                                     REF                            REF                      
   2                                               0.80                                   0.54                               1.20                  0.278    0.87   0.57   1.32    0.508    0.78   0.49   1.24    0.295
   3                                               0.74                                   0.50                               1.10                  0.132    0.82   0.54   1.24    0.340    0.69   0.44   1.09    0.116
   4                                               0.98                                   0.67                               1.44                  0.925    1.12   0.74   1.68    0.601    0.89   0.57   1.40    0.627
   5 (most deprived)                               1.02                                   0.71                               1.46                  0.913    1.37   0.94   1.99    0.105    0.89   0.59   1.35    0.582
  Year of diagnosis                                1.09                                   1.06                               1.12                 \<0.001   1.10   1.06   1.13   \<0.001   1.09   1.06   1.13   \<0.001

Abbreviations: CI, confidence interval; CNS=central nervous system; ICCC=International Classification of Childhood Cancer; IRR=incidence rate ratio; REF=reference category; SPPCS=Specialist Paediatric Palliative Care Service.
